P073 - Initial results comparing high resolution micro-ultrasound with multiparametric magnetic resonance imaging for prostate cancer detection

Publication date: November 2019Source: European Urology Supplements, Volume 18, Issue 11Author(s): T.V.R. Perez
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research

Related Links:

ConclusionsThis article and the accompanying video show different MRGB techniques. The advantages and disadvantages of the three biopsy techniques, as well as the clinical setting in which each biopsy strategy is being used in our hospital, are discussed. Fus-MRGB is our first choice for prostate biopsy. Direct inbore-MRGB is used in difficult lesions but is mainly used as a “problem solver” (eg, a negative biopsy with a high suspicion for clinically significant prostate cancer). In our opinion, cog-MRGB is best for sampling larger and diffuse lesions.Patient summaryThis third surgery in motion contribution sho...
Source: European Urology - Category: Urology & Nephrology Source Type: research
DiscussionThe primary objective is to determine whether mpMRI can improve PCa detection and characterisation. The key secondary objective is to determine whether MRI/US fusion-guided biopsy can reduce the number of false-negative biopsies. Ethical approval was obtained from the East of Scotland Research Ethics Committee 1 (14/ES/1070) on 20 November 2014. The results of this study will be used for publication and presentation in national and international journals and at scientific conferences.Trial registrationClinicalTrials.gov,NCT02745496. Retrospectively registered on 20 April 2016.
Source: Trials - Category: Research Source Type: clinical trials
Abstract The use of multiparametric magnetic resonance imaging (mpMRI) is becoming increasingly more important for the primary diagnostics of prostate cancer (PCa) and for monitoring under active surveillance. Current studies confirmed that the use of mpMRI can increase the detection of clinically significant PCa and reduce the detection rate of insignificant PCa as well as the rate of unnecessary biopsies. The information from mpMRI can be cognitively used for in-bore biopsy and using fusion biopsy systems. There are no clear recommendations on the access approach for fusion biopsy (e. g. transrectal or perinea...
Source: Der Urologe. Ausg. A - Category: Urology & Nephrology Authors: Tags: Urologe A Source Type: research
Publication date: November 2019Source: European Urology Supplements, Volume 18, Issue 11Author(s): O. Rojas Claros, F. Muttin, R.R.T. Barbosa, A.C. Gallardo, E. Barret, F. Rozet, N. Cathala, D. Prapotnich, A. Mombet, R. Sanchez-Salas, X. Cathelineau
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
This study was registered with Japan Registry of Clinical Trials (jRCTs052190026). PMID: 31701044 [PubMed]
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Tags: Contemp Clin Trials Commun Source Type: research
ConclusionsWe demonstrate the safety and feasibility of performing transperineal prostate biopsy using cognitive MRI/biplanar ultrasound fusion guidance. The described technique affords the safety benefits of the transperineal approach as well as obviates the need for a formal fusion platform. Additionally, this method can conveniently be performed under local anesthesia with acceptable tolerability.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
To evaluate retrospectively the diagnostic usefulness of transrectal ultrasound (TRUS)-guided targeted biopsy (TB) for transition zone (TZ) prostate cancer (PCa) in patients with prebiopsy magnetic resonance imaging (MRI).
Source: Clinical Radiology - Category: Radiology Authors: Source Type: research
ConclusionsPre-biopsy mpMRI for clinically suspected prostate cancer is emerging as a standard of practice in Ireland. International guidelines are also changing to reflect latest clinical trial evidence. Private health insurance providers should amend their policies to reflect current clinical practices already adopted in the public sector.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
CONCLUSION: None of the Software platforms have demonstrated superiority in the diagnosis of cancer, although their results are superior to those obtained through standard and cognitive biopsy and are more affordable than the "In bore" biopsy. It is necessary to standardize the publications to be able to compare results (classification of risk in resonance, number of cores, approach). The diagnosis of cancer guided by MRI should be a factor to consider in therapeutic decision nomograms. The next challenge is the incorporation of these systems in the protocols of active surveillance and Focal Therapy. PMID: 31...
Source: Archivos Espanoles de Urologia - Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research
Every year, tens thousands of men in the United States are diagnosed with low-risk prostate cancer. Most are told that they don ’t need treatment other than “active surveillance” to monitor their slow-growing tumors. Now, UCLA physicians have shown that the best way to proceed with this is by starting out with an MRI-guided prostate biopsy.In the past, doctors relied on ultrasound to guide a biopsy needle into the prostate. However, ultrasound doesn ’t allow the visualization of prostate tumors, so a biopsy may have missed a tumor. Over the past decade, it’s become possible to instead perform ...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
More News: Cancer | Cancer & Oncology | MRI Scan | Prostate Cancer | Ultrasound | Urology & Nephrology